Evidence map›Paper›PMID 26286360›Full record

ArticleJournal of lipid research2015

Activity of neutral and alkaline ceramidases on fluorogenic N-acylated coumarin-containing aminodiols.

Mireia Casasampere, Luz Camacho, Francesca Cingolani, Josefina Casas, Meritxell Egido-Gabás, José Luís Abad, Carmen Bedia, Ruijuan Xu, Kai Wang, Daniel Canals and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Mireia CasasampereConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Luz CamachoConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Francesca CingolaniConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Josefina CasasConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Meritxell Egido-GabásConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
José Luís AbadConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Carmen BediaConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Ruijuan XuDepartment of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8155.
Kai WangDepartment of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8155.
Daniel CanalsDepartment of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8155.
Yusuf A HannunDepartment of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8155.
Cungui MaoDepartment of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8155.
Gemma FabriasConsejo Superior de Investigaciones Científicas (CSIC), Institut de Química Avançada de Catalunya (IQAC-CSIC), Research Unit on Bioactive Molecules (RUBAM), 08034 Barcelona, Spain.
Institute of Advanced Chemistry of Catalonia · ESStony Brook University · USConsejo Superior de Investigaciones Científicas · ESState University of New York · US

Funding

The Role of Ceramidases in Cancer ChemotherapyR01CA163825 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI MAO, CUNGUI · 2012 to 2016
$1.6M
Neutral Ceramidase in Colon CancerR01CA172517 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2013 to 2016
$1.3M
NCI NIH HHS R01 CA163825NCI NIH HHS R01CA163825NCI NIH HHS R01 CA172517
6 · The paper itself

Abstract

Ceramidases catalyze the cleavage of ceramides into sphingosine and fatty acids. Previously, we reported on the use of the RBM14 fluorogenic ceramide analogs to determine acidic ceramidase activity. In this work, we investigated the activity of other amidohydrolases on RBM14 compounds. Both bacterial and human purified neutral ceramidases (NCs), as well as ectopically expressed mouse neutral ceramidase hydrolyzed RBM14 with different selectivity, depending on the N-acyl chain length. On the other hand, microsomes from alkaline ceramidase (ACER)3 knockdown cells were less competent at hydrolyzing RBM14C12, RBM12C14, and RBM14C16 than controls, while microsomes from ACER2 and ACER3 overexpressing cells showed no activity toward the RBM14 substrates. Conversely, N-acylethanolamine-hydrolyzing acid amidase (NAAA) overexpressing cells hydrolyzed RBM14C14 and RBM14C16 at acidic pH. Overall, NC, ACER3, and, to a lesser extent, NAAA hydrolyze fluorogenic RBM14 compounds. Although the selectivity of the substrates toward ceramidases can be modulated by the length of the N-acyl chain, none of them was specific for a particular enzyme. Despite the lack of specificity, these substrates should prove useful in library screening programs aimed at identifying potent and selective inhibitors for NC and ACER3.

Indexed as

AcylationAlkaline CeramidaseAnimalsCeramidesCoumarinsFluorescent DyesGene Knockdown TechniquesHCT116 CellsHEK293 CellsHeLa CellsHumansHydrolysisMass SpectrometryMiceNeutral CeramidaseSphingolipidsAlkaline CeramidaseCeramidesCoumarinsFluorescent DyesNeutral CeramidaseSphingolipidsceramidesenzymologyhigh throughput screeninglipidsmass spectrometrysphingolipidsumbelliferone

Identifiers

PMID26286360
PMCPMC4583077
OpenAlexW2106964401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.